Post-acute health care costs following SARS-CoV-2 infection: A retrospective cohort study of among 531,182 matched adults
McNaughton, C. D.; Austin, P. C.; Li, Z.; Sivaswamy, A.; Fang, T.; Abdel-Qadir, H.; Udell, J. A.; Wodchis, W.; Lee, D. S.; Mostarac, I.; Atzema, C. L.
Show abstract
Post-acute health care costs following SARS-CoV-2 infection are not known. Beginning 56 days following SARS-CoV-2 polymerase chain reaction (PCR) testing, we compared person-specific total and component health care costs across their distribution for the following year (test-positive versus test-negative, matched people; January 1, 2020-March 31, 2021). For 531,182 individuals, mean person-specific total health care costs were $513.83 (95% CI $387.37-$638.40) higher for test-positive females and $459.10 (95% CI $304.60-$615.32) higher for test-positive males, or >10% increase in mean per-capita costs, driven by hospitalization, long-term care, and complex continuing care costs. At the 99th percentile of each subgroup, person-specific health care costs were $12,533.00 (95% CI $9,008.50-$16,473.00) higher for test-positive females and $14,604.00 (95% CI $9,565.50-$19,506.50) for test-positive males, driven by hospitalization, specialist (males), and homecare costs (females). Cancer costs were lower. Six-month and 1-year costs differences were similar. These findings can inform planning for post-acute SARS-CoV-2 health care costs.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Projected geographic disparities in healthcare worker absenteeism from COVID-19 school closures and the economic feasibility of child care subsidies: a simulation study 92%
- Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study 91%
- Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) 90%
Similar papers in this journal
Similar papers in this journal
- Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes 92%
- Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England 91%
- Evidence of Leaky Protection Following COVID-19 Vaccination and SARS-CoV-2 Infection in a US Correctional Facility Population 91%
Similar papers in this journal
- Effectiveness of a Fourth Dose of COVID-19 Vaccine among Long-Term Care Residents in Ontario, Canada 92%
- Risk Of Hospitalisation With COVID-19 Among Teachers Compared To Healthcare Workers And Other Working-Age Adults. A Nationwide Case-Control Study 91%
- Post-discharge Acute Care and Outcomes in the Era of Readmission Reduction: A National Retrospective Cohort Study of Medicare Beneficiaries in the United States 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.